Natural killer cells in multiple sclerosis: foe or friends?
Authors:
Open Access
- 4 April 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1500770
Abstract
Multiple sclerosis (MS) is an immune-mediated disorder involving the central nervous system (CNS), in which demyelination is caused. The initiation and progression of MS is thought to depend largely on CD4+ T lymphocytes, yet new data has emphasized the involvement of the innate immune system in the MS disease responses. Generally, several types of immune cells play a part, with natural killer (NK) cells being essential. Different subsets of natural killer cells function differently within the course of an autoimmune disease, such as MS. There are mainly two types of natural killers in humans: immature CD56bright CD16– and mature CD56dim CD16+ natural killers, together with their respective subtypes. Factors from natural killers expand the T cell population and control the process by which native CD4+ T cells differentiate into Th1 or Th2 lymphocytes, which affect autoimmune responses. Natural killer subsets CD56bright and CD56dim may have differing roles in MS development. The impact of these NK cell subsets is influenced by factors such as Granzymes, genetics, infections, TLR, and HSP. We reviewed and evaluated the relationship between natural killer cells and MS.Keywords
This publication has 154 references indexed in Scilit:
- The association between various viral infections and multiple sclerosis: An umbrella review on systematic review and meta‐analysisReviews in Medical Virology, 2023
- The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapiesHealth Science Reports, 2022
- Natural killer cells in inflammatory autoimmune diseasesClinical & Translational Immunology, 2021
- Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individualsEuropean Journal of Immunology, 2014
- HINT1 peptide/Hsp70 complex induces NK‐cell‐dependent immunoregulation in a model of autoimmune demyelinationEuropean Journal of Immunology, 2014
- Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and functionCytometry Part A, 2013
- Interleukin‐2/interleukin‐2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammationAnnals of Neurology, 2010
- Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosisAnnals of Neurology, 2009
- Understanding the role of natural killer cell receptors and their human leukocyte antigen ligands in multiple sclerosisAnnals of Neurology, 2009
- Effect of 1,25(OH)2-Vitamin D3 on the Activation of Natural Killer Cells: Role of Protein Kinase C and Extracellular CalciumExperimental and Molecular Pathology, 1999